Mary Elizabeth Wilson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Travel | 38 | 2018 | 806 | 4.200 |
Why?
|
| Dengue | 13 | 2017 | 257 | 2.690 |
Why?
|
| Medical Tourism | 3 | 2015 | 51 | 1.300 |
Why?
|
| Dengue Virus | 6 | 2013 | 202 | 1.260 |
Why?
|
| Travel Medicine | 11 | 2014 | 83 | 1.170 |
Why?
|
| Alphavirus Infections | 4 | 2012 | 20 | 1.130 |
Why?
|
| Yellow Fever | 5 | 2014 | 54 | 0.940 |
Why?
|
| Insect Vectors | 2 | 2016 | 136 | 0.930 |
Why?
|
| Communicable Diseases | 7 | 2014 | 874 | 0.930 |
Why?
|
| Malaria | 10 | 2018 | 1246 | 0.920 |
Why?
|
| Yellow Fever Vaccine | 5 | 2014 | 38 | 0.870 |
Why?
|
| Infectious Disease Medicine | 2 | 2014 | 51 | 0.850 |
Why?
|
| Endemic Diseases | 4 | 2013 | 189 | 0.690 |
Why?
|
| Chikungunya virus | 3 | 2010 | 54 | 0.690 |
Why?
|
| Internationality | 5 | 2016 | 1007 | 0.640 |
Why?
|
| Sentinel Surveillance | 6 | 2018 | 293 | 0.630 |
Why?
|
| Communicable Diseases, Emerging | 4 | 2009 | 150 | 0.610 |
Why?
|
| Diarrhea | 6 | 2018 | 1316 | 0.580 |
Why?
|
| Aedes | 2 | 2016 | 100 | 0.560 |
Why?
|
| Tick-Borne Diseases | 2 | 2009 | 37 | 0.510 |
Why?
|
| Fever | 6 | 2014 | 1603 | 0.500 |
Why?
|
| Milk, Human | 2 | 2010 | 490 | 0.490 |
Why?
|
| Filariasis | 1 | 2015 | 26 | 0.490 |
Why?
|
| Skin Diseases, Parasitic | 2 | 2014 | 14 | 0.480 |
Why?
|
| Disease Outbreaks | 5 | 2016 | 1759 | 0.430 |
Why?
|
| Brazil | 6 | 2016 | 1248 | 0.410 |
Why?
|
| Communicable Disease Control | 3 | 2011 | 856 | 0.410 |
Why?
|
| Sports | 2 | 2016 | 698 | 0.400 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2005 | 248 | 0.390 |
Why?
|
| Breast Feeding | 2 | 2010 | 1364 | 0.380 |
Why?
|
| Neglected Diseases | 1 | 2011 | 67 | 0.350 |
Why?
|
| Rickettsia Infections | 1 | 2009 | 8 | 0.330 |
Why?
|
| Virus Diseases | 1 | 2015 | 718 | 0.310 |
Why?
|
| Vaccination | 6 | 2014 | 3426 | 0.300 |
Why?
|
| Patient Preference | 1 | 2015 | 952 | 0.280 |
Why?
|
| Serologic Tests | 3 | 2013 | 382 | 0.250 |
Why?
|
| Commerce | 3 | 2018 | 611 | 0.250 |
Why?
|
| Animal Diseases | 1 | 2004 | 12 | 0.230 |
Why?
|
| Typhoid Fever | 3 | 2014 | 197 | 0.210 |
Why?
|
| Disease Vectors | 3 | 2012 | 61 | 0.210 |
Why?
|
| Adoption | 1 | 2003 | 97 | 0.210 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2010 | 1354 | 0.210 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 3475 | 0.200 |
Why?
|
| Ticks | 1 | 2002 | 72 | 0.190 |
Why?
|
| Health Care Costs | 1 | 2015 | 3242 | 0.190 |
Why?
|
| Public Health | 2 | 2017 | 2680 | 0.190 |
Why?
|
| Bites and Stings | 1 | 2002 | 95 | 0.180 |
Why?
|
| Tropical Medicine | 2 | 2014 | 52 | 0.180 |
Why?
|
| Antimalarials | 3 | 2015 | 913 | 0.160 |
Why?
|
| Education, Medical | 1 | 2011 | 1746 | 0.160 |
Why?
|
| Asia | 4 | 2018 | 628 | 0.150 |
Why?
|
| Hepatitis B | 2 | 2013 | 707 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 5370 | 0.140 |
Why?
|
| Humans | 51 | 2018 | 765968 | 0.130 |
Why?
|
| Insect Repellents | 1 | 2016 | 18 | 0.130 |
Why?
|
| Risk Assessment | 6 | 2014 | 24282 | 0.130 |
Why?
|
| Diagnostic Errors | 2 | 2013 | 1275 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2016 | 4058 | 0.120 |
Why?
|
| Crowding | 1 | 2016 | 142 | 0.120 |
Why?
|
| Tungiasis | 1 | 2014 | 3 | 0.120 |
Why?
|
| Larva Migrans | 1 | 2014 | 7 | 0.110 |
Why?
|
| Parasitic Diseases | 1 | 2014 | 76 | 0.110 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2018 | 667 | 0.110 |
Why?
|
| Dengue Vaccines | 1 | 2013 | 16 | 0.110 |
Why?
|
| Hepatitis A | 1 | 2014 | 126 | 0.110 |
Why?
|
| Topography, Medical | 1 | 2013 | 37 | 0.110 |
Why?
|
| Influenza, Human | 4 | 2016 | 1539 | 0.100 |
Why?
|
| Risk | 3 | 2014 | 9591 | 0.100 |
Why?
|
| Models, Biological | 1 | 2009 | 9443 | 0.100 |
Why?
|
| Malaria, Vivax | 1 | 2014 | 168 | 0.100 |
Why?
|
| Mosquito Control | 1 | 2012 | 110 | 0.090 |
Why?
|
| Mass Screening | 3 | 2013 | 5446 | 0.090 |
Why?
|
| Americas | 1 | 2010 | 109 | 0.090 |
Why?
|
| Antibodies, Viral | 2 | 2013 | 3211 | 0.090 |
Why?
|
| Frostbite | 1 | 2010 | 24 | 0.080 |
Why?
|
| Skin Diseases | 2 | 2013 | 1088 | 0.080 |
Why?
|
| Rickettsia | 1 | 2009 | 11 | 0.080 |
Why?
|
| Honduras | 1 | 2009 | 39 | 0.080 |
Why?
|
| Health Education | 2 | 2014 | 1060 | 0.080 |
Why?
|
| Boston | 7 | 2016 | 9338 | 0.080 |
Why?
|
| Altitude Sickness | 1 | 2010 | 93 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2014 | 3230 | 0.080 |
Why?
|
| Yellow fever virus | 1 | 2008 | 23 | 0.080 |
Why?
|
| Italy | 1 | 2010 | 854 | 0.080 |
Why?
|
| Meningococcal Infections | 1 | 2008 | 78 | 0.080 |
Why?
|
| Singapore | 1 | 2009 | 297 | 0.070 |
Why?
|
| Seasons | 1 | 2014 | 1524 | 0.070 |
Why?
|
| Primary Prevention | 2 | 2008 | 1187 | 0.070 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2008 | 136 | 0.070 |
Why?
|
| Female | 23 | 2018 | 396112 | 0.070 |
Why?
|
| Physicians, Primary Care | 1 | 2014 | 622 | 0.070 |
Why?
|
| Zoonoses | 1 | 2008 | 181 | 0.070 |
Why?
|
| International Cooperation | 2 | 2011 | 1432 | 0.070 |
Why?
|
| Hospitalization | 1 | 2007 | 10808 | 0.070 |
Why?
|
| Young Adult | 12 | 2018 | 59889 | 0.070 |
Why?
|
| Cost of Illness | 1 | 2017 | 1950 | 0.070 |
Why?
|
| Animals | 8 | 2016 | 168764 | 0.070 |
Why?
|
| Virulence | 1 | 2010 | 1289 | 0.070 |
Why?
|
| Measles | 1 | 2008 | 180 | 0.070 |
Why?
|
| Blood | 1 | 2009 | 597 | 0.060 |
Why?
|
| Immunization | 2 | 2016 | 1219 | 0.060 |
Why?
|
| Counseling | 1 | 2013 | 1551 | 0.060 |
Why?
|
| Immunoglobulin M | 1 | 2010 | 1528 | 0.060 |
Why?
|
| Geography | 1 | 2007 | 652 | 0.060 |
Why?
|
| Self Report | 1 | 2016 | 3770 | 0.060 |
Why?
|
| Adult | 18 | 2018 | 223044 | 0.060 |
Why?
|
| Middle Aged | 16 | 2018 | 223009 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2013 | 1203 | 0.060 |
Why?
|
| Male | 20 | 2018 | 363698 | 0.060 |
Why?
|
| Medication Adherence | 1 | 2015 | 2192 | 0.050 |
Why?
|
| Antibodies, Bacterial | 1 | 2009 | 1476 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2013 | 2692 | 0.050 |
Why?
|
| Caribbean Region | 2 | 2013 | 193 | 0.050 |
Why?
|
| Accidents, Occupational | 1 | 2004 | 251 | 0.050 |
Why?
|
| Patient Care Planning | 1 | 2008 | 906 | 0.050 |
Why?
|
| Africa South of the Sahara | 2 | 2018 | 751 | 0.050 |
Why?
|
| Plant Diseases | 1 | 2004 | 184 | 0.050 |
Why?
|
| Risk Factors | 5 | 2016 | 74840 | 0.050 |
Why?
|
| Anti-Infective Agents | 1 | 2010 | 986 | 0.050 |
Why?
|
| Population Dynamics | 1 | 2004 | 314 | 0.050 |
Why?
|
| Population Surveillance | 2 | 2009 | 2590 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 4528 | 0.050 |
Why?
|
| Vaccines | 1 | 2010 | 841 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2013 | 3956 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2014 | 3615 | 0.040 |
Why?
|
| Health Services Research | 1 | 2008 | 1808 | 0.040 |
Why?
|
| Emigration and Immigration | 1 | 2004 | 405 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 1808 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2012 | 3050 | 0.040 |
Why?
|
| United States | 5 | 2014 | 72903 | 0.040 |
Why?
|
| Hepatitis, Viral, Human | 2 | 2010 | 141 | 0.040 |
Why?
|
| Bacterial Vaccines | 1 | 2002 | 400 | 0.040 |
Why?
|
| Demography | 1 | 2004 | 1641 | 0.040 |
Why?
|
| Comorbidity | 1 | 2013 | 10563 | 0.040 |
Why?
|
| Family Health | 1 | 2003 | 1253 | 0.040 |
Why?
|
| Adolescent | 6 | 2013 | 88835 | 0.040 |
Why?
|
| Aged | 9 | 2018 | 171117 | 0.040 |
Why?
|
| Occupational Medicine | 1 | 2018 | 116 | 0.030 |
Why?
|
| Infant | 4 | 2013 | 36386 | 0.030 |
Why?
|
| Pregnancy | 2 | 2016 | 30260 | 0.030 |
Why?
|
| Incidence | 2 | 2013 | 21480 | 0.030 |
Why?
|
| Lyme Disease | 1 | 2002 | 631 | 0.030 |
Why?
|
| Databases, Factual | 2 | 2010 | 8067 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 2 | 2010 | 7425 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2010 | 4533 | 0.030 |
Why?
|
| North America | 1 | 2018 | 1285 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2013 | 42500 | 0.030 |
Why?
|
| Respiratory Tract Infections | 2 | 2013 | 1008 | 0.030 |
Why?
|
| Holidays | 1 | 2013 | 41 | 0.030 |
Why?
|
| Child | 5 | 2013 | 80564 | 0.030 |
Why?
|
| Consultants | 1 | 2013 | 57 | 0.030 |
Why?
|
| Antidiarrheals | 1 | 2012 | 46 | 0.030 |
Why?
|
| Typhoid-Paratyphoid Vaccines | 1 | 2012 | 40 | 0.020 |
Why?
|
| Research Design | 1 | 2008 | 6209 | 0.020 |
Why?
|
| Hepatitis B Antibodies | 1 | 2013 | 156 | 0.020 |
Why?
|
| Host-Parasite Interactions | 1 | 2014 | 302 | 0.020 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2013 | 294 | 0.020 |
Why?
|
| Developing Countries | 3 | 2013 | 2911 | 0.020 |
Why?
|
| Latin America | 1 | 2013 | 416 | 0.020 |
Why?
|
| Friends | 1 | 2012 | 151 | 0.020 |
Why?
|
| Europe | 1 | 2018 | 3423 | 0.020 |
Why?
|
| Health Status | 1 | 2003 | 4080 | 0.020 |
Why?
|
| Stomatognathic Diseases | 1 | 2010 | 21 | 0.020 |
Why?
|
| Decision Making | 2 | 2014 | 3965 | 0.020 |
Why?
|
| Hepatitis B virus | 1 | 2013 | 530 | 0.020 |
Why?
|
| Influenza Vaccines | 1 | 2016 | 778 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2014 | 1138 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2014 | 1591 | 0.020 |
Why?
|
| Mefloquine | 1 | 2007 | 55 | 0.020 |
Why?
|
| Primaquine | 1 | 2007 | 28 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2012 | 644 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 2721 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3807 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 3432 | 0.020 |
Why?
|
| Prevalence | 2 | 2013 | 15842 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 59489 | 0.010 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2010 | 454 | 0.010 |
Why?
|
| Health Policy | 1 | 2017 | 2698 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 15652 | 0.010 |
Why?
|
| Urinary Tract Infections | 1 | 2010 | 805 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 2009 | 939 | 0.010 |
Why?
|
| Syndrome | 1 | 2009 | 3271 | 0.010 |
Why?
|
| Hemorrhagic Fevers, Viral | 1 | 2002 | 23 | 0.010 |
Why?
|
| Central Nervous System Infections | 1 | 2002 | 61 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 39193 | 0.010 |
Why?
|
| Family | 1 | 2012 | 3209 | 0.010 |
Why?
|
| Health Behavior | 1 | 2012 | 2650 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2014 | 81514 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3925 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 3278 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 12976 | 0.010 |
Why?
|
| Consensus | 1 | 2007 | 3202 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 14751 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2009 | 2511 | 0.010 |
Why?
|
| Sex Factors | 1 | 2010 | 10603 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2008 | 4300 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 26318 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 54802 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2009 | 6853 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 40065 | 0.000 |
Why?
|
| Algorithms | 1 | 2006 | 14071 | 0.000 |
Why?
|